The Capital Group Companies, Inc. - Net Worth and Insider Trading
The Capital Group Companies, Inc. Net Worth
The estimated net worth of The Capital Group Companies, Inc. is at least $153 Million dollars as of 2025-01-15. The Capital Group Companies, Inc. is the 2201 Interest of corporation controlled by you of Ocumension Therapeutics and owns about 41,178,466 shares of Ocumension Therapeutics (HKSE:01477) stock worth over $153 Million. Details can be seen in The Capital Group Companies, Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that The Capital Group Companies, Inc. has not made any transactions after 2023-10-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of The Capital Group Companies, Inc.
The Capital Group Companies, Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, The Capital Group Companies, Inc. owns 1 companies in total, including Ocumension Therapeutics (HKSE:01477) .
Insider Ownership Summary of The Capital Group Companies, Inc.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:01477 | Ocumension Therapeutics | 2023-10-30 | 2201 Interest of corporation controlled by you |
The Capital Group Companies, Inc. Latest Holdings Summary
The Capital Group Companies, Inc. currently owns a total of 1 stock. The Capital Group Companies, Inc. owns 41,178,466 shares of Ocumension Therapeutics (HKSE:01477) as of October 30, 2023, with a value of $153 Million.
Latest Holdings of The Capital Group Companies, Inc.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:01477 | Ocumension Therapeutics | 2023-10-30 | 41,178,466 | 3.72 | 153,183,894 |
Holding Weightings of The Capital Group Companies, Inc.
The Capital Group Companies, Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, The Capital Group Companies, Inc. has made a total of 3 transactions in Ocumension Therapeutics (HKSE:01477) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Ocumension Therapeutics is the sale of 427,000 shares on October 30, 2023, which brought The Capital Group Companies, Inc. around $3 Million.
Insider Trading History of The Capital Group Companies, Inc.
- 1
The Capital Group Companies, Inc. Trading Performance
GuruFocus tracks the stock performance after each of The Capital Group Companies, Inc.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by The Capital Group Companies, Inc. is -34.66%. GuruFocus also compares The Capital Group Companies, Inc.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by The Capital Group Companies, Inc. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how The Capital Group Companies, Inc.'s insider trading performs compared to the benchmark.
Performance of The Capital Group Companies, Inc.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -18.37 | | | | | |
| Relative Return to S&P 500(%) | -21.45 | | | | | |
The Capital Group Companies, Inc. Ownership Network
Ownership Network List of The Capital Group Companies, Inc.
Ownership Network Relation of The Capital Group Companies, Inc.
The Capital Group Companies, Inc. Owned Company Details
What does Ocumension Therapeutics do?
Who are the key executives at Ocumension Therapeutics?
The Capital Group Companies, Inc. is the 2201 Interest of corporation controlled by you of Ocumension Therapeutics. Other key executives at Ocumension Therapeutics include 2101 Beneficial owner Liu Ye , 2201 Interest of corporation controlled by you 6 Dimensions Capital GP, LLC , and 2101 Beneficial owner 6 Dimensions Capital, L.P. .
Ocumension Therapeutics (HKSE:01477) Insider Trades Summary
Over the past 18 months, The Capital Group Companies, Inc. made 1 insider transaction in Ocumension Therapeutics (HKSE:01477) with a net sale of 427,000. Other recent insider transactions involving Ocumension Therapeutics (HKSE:01477) include a net sale of 0 shares made by Liu Ye , a net sale of 3,800,000 shares made by Temasek Holdings (private) Limited , and a net purchase of 150,000 shares made by Boyu Capital Group Holdings Ltd .
In summary, during the past 3 months, insiders sold 0 shares of Ocumension Therapeutics (HKSE:01477) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,227,000 shares of Ocumension Therapeutics (HKSE:01477) were sold and 150,000 shares were bought by its insiders, resulting in a net sale of 4,077,000 shares.
Ocumension Therapeutics (HKSE:01477)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ocumension Therapeutics Insider Transactions
The Capital Group Companies, Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for The Capital Group Companies, Inc.. Currently GuruFocus does not have mailing address information for The Capital Group Companies, Inc..
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
